We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLF
7176
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$0 ﹤0.01%
+22
New +$25
IMUC
7177
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$0 ﹤0.01%
50
CGG
7178
DELISTED
CGG
CGG
$0 ﹤0.01%
30
ARGS
7179
DELISTED
Argos Therapeutics, Inc.
ARGS
$0 ﹤0.01%
38
+20
+111% +$1.27K
DST
7180
PUT
DELISTED
DST Systems Inc.
DST
-200
Closed -$11K
PGEM
7181
CALL
DELISTED
Ply Gem Holdings, Inc.
PGEM
-300
Closed -$5K
PGEM
7182
PUT
DELISTED
Ply Gem Holdings, Inc.
PGEM
-500
Closed -$8K
REXX
7183
DELISTED
Rex Energy Corporation
REXX
-6
Closed
OREX
7184
CALL
DELISTED
Orexigen Therapeutics, Inc.
OREX
-860
Closed -$1K
OREX
7185
DELISTED
Orexigen Therapeutics, Inc.
OREX
$0 ﹤0.01%
100
-3,684
-97% -$14.5K
OREX
7186
PUT
DELISTED
Orexigen Therapeutics, Inc.
OREX
-1,450
Closed -$3K
TNH
7187
DELISTED
Terra Nitrogen
TNH
-244
Closed -$26K
BOBE
7188
CALL
DELISTED
Bob Evans Farms, Inc.
BOBE
-37,700
Closed -$2.01M
BCR
7189
CALL
DELISTED
CR Bard Inc.
BCR
-900
Closed -$202K
HNH
7190
DELISTED
Handy & Harman Holdings Ltd.
HNH
$0 ﹤0.01%
+13
New +$347
DYN.WS
7191
DELISTED
Dynegy Inc,
DYN.WS
$0 ﹤0.01%
7
BCS.PRA.CL
7192
DELISTED
Barclays Bank Plc Series 3
BCS.PRA.CL
-1,186
Closed -$30K
QUNR
7193
DELISTED
Qunar Cayman Islands Limited
QUNR
-13,000
Closed -$392K
DSCI
7194
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
-60
Closed
FDML
7195
DELISTED
Federal-Mogul Holdings Corporation
FDML
-15,874
Closed -$164K
ACAS
7196
CALL
DELISTED
American Capital Ltd
ACAS
-81,100
Closed -$1.45M
ACAS
7197
DELISTED
American Capital Ltd
ACAS
-7,174,561
Closed -$129M
ACAS
7198
PUT
DELISTED
American Capital Ltd
ACAS
-7,800
Closed -$140K
EDE
7199
DELISTED
Empire District Electric
EDE
-72,697
Closed -$2.48M
AIXG
7200
DELISTED
Aixtron SE
AIXG
-54
Closed

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.